98 related articles for article (PubMed ID: 12485868)
1. Activation of the c-Jun N terminal kinase pathway in an animal model of Parkinson's disease.
Willesen MG; Gammeltoft S; Vaudano E
Ann N Y Acad Sci; 2002 Nov; 973():237-40. PubMed ID: 12485868
[TBL] [Abstract][Full Text] [Related]
2. MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo.
Saporito MS; Thomas BA; Scott RW
J Neurochem; 2000 Sep; 75(3):1200-8. PubMed ID: 10936203
[TBL] [Abstract][Full Text] [Related]
3. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Hayley S; Crocker SJ; Smith PD; Shree T; Jackson-Lewis V; Przedborski S; Mount M; Slack R; Anisman H; Park DS
J Neurosci; 2004 Feb; 24(8):2045-53. PubMed ID: 14985447
[TBL] [Abstract][Full Text] [Related]
4. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.
Boyd JD; Jang H; Shepherd KR; Faherty C; Slack S; Jiao Y; Smeyne RJ
Brain Res; 2007 Oct; 1175():107-16. PubMed ID: 17884023
[TBL] [Abstract][Full Text] [Related]
5. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
Wang Y; Zhang Y; Wei Z; Li H; Zhou H; Zhang Z; Zhang Z
J Neurol Sci; 2009 Oct; 285(1-2):172-7. PubMed ID: 19604516
[TBL] [Abstract][Full Text] [Related]
6. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
7. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.
Karunakaran S; Diwakar L; Saeed U; Agarwal V; Ramakrishnan S; Iyengar S; Ravindranath V
FASEB J; 2007 Jul; 21(9):2226-36. PubMed ID: 17369508
[TBL] [Abstract][Full Text] [Related]
8. SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease.
Wang W; Shi L; Xie Y; Ma C; Li W; Su X; Huang S; Chen R; Zhu Z; Mao Z; Han Y; Li M
Neurosci Res; 2004 Feb; 48(2):195-202. PubMed ID: 14741394
[TBL] [Abstract][Full Text] [Related]
9. JNK-mediated activation of ATF2 contributes to dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease.
Huang Q; Du X; He X; Yu Q; Hu K; Breitwieser W; Shen Q; Ma S; Li M
Exp Neurol; 2016 Mar; 277():296-304. PubMed ID: 26515688
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Doo AR; Kim ST; Kim SN; Moon W; Yin CS; Chae Y; Park HK; Lee H; Park HJ
Neurol Res; 2010 Feb; 32 Suppl 1():88-91. PubMed ID: 20034453
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside in the MPTP-induced mouse model of Parkinson's disease: Involvement of reactive oxygen species-mediated JNK, P38 and mitochondrial pathways.
He H; Wang S; Tian J; Chen L; Zhang W; Zhao J; Tang H; Zhang X; Chen J
Eur J Pharmacol; 2015 Nov; 767():175-82. PubMed ID: 26477638
[TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway.
Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson C; Wolf CR; Gama MJ
Mol Neurobiol; 2012 Jun; 45(3):466-77. PubMed ID: 22539231
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
[TBL] [Abstract][Full Text] [Related]
14. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease.
Xia XG; Harding T; Weller M; Bieneman A; Uney JB; Schulz JB
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10433-8. PubMed ID: 11504916
[TBL] [Abstract][Full Text] [Related]
16. [Effect of phosphorylated c-Jun expression on COX-2 expression in the substantia nigra of MPTP mouse model of subacute Parkinson disease].
Wang YS; Zhou JP; Wei ZF; Tian QY; Zhou HX; Zhang YX
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1199-202, 1205. PubMed ID: 17715026
[TBL] [Abstract][Full Text] [Related]
17. Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.
Pattarini R; Smeyne RJ; Morgan JI
Neuroscience; 2007 Mar; 145(2):654-68. PubMed ID: 17258864
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease.
Benner EJ; Mosley RL; Destache CJ; Lewis TB; Jackson-Lewis V; Gorantla S; Nemachek C; Green SR; Przedborski S; Gendelman HE
Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9435-40. PubMed ID: 15197276
[TBL] [Abstract][Full Text] [Related]
19. MPTP activates ASK1-p38 MAPK signaling pathway through TNF-dependent Trx1 oxidation in parkinsonism mouse model.
Ray A; Sehgal N; Karunakaran S; Rangarajan G; Ravindranath V
Free Radic Biol Med; 2015 Oct; 87():312-25. PubMed ID: 26164633
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility.
Hofele K; Sedelis M; Auburger GW; Morgan S; Huston JP; Schwarting RK
Exp Neurol; 2001 Mar; 168(1):116-22. PubMed ID: 11170726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
